journal article·2020-08

Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics

Sudip Mukherjee, Vijay Sagar Madamsetty, Dwaipayan Bhattacharya, Sayan Roy Chowdhury, Manash Kumar Paul, Anubhab Mukherjee

Advanced Functional Materials· Volume 30· Issue 35
Publisher page

Abstract

Abstract Recent times have witnessed an upsurge in the incidence of neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Prion disease, and amyotrophic lateral sclerosis. The treatment of the same remains a daunting challenge due to the limited access of therapeutic moieties across the blood–brain barrier. Engineered nanoparticles with a size less than 100 nm provide multifunctional abilities for solving these biomedical and pharmacological issues due to their unique physico‐chemical properties along with capability to cross the blood–brain barrier. Needless to mention, there is a scarcity of review articles summarizing recent developments of various nanomaterials including liposomes, polymeric nanoparticles, metal nanoparticles, and bio‐nanoparticles toward the therapeutic and theranostics applications for various neurodegenerative disorders. Here, a broad spectrum of nanomedicinal approaches to eradicate neurodegenerative disorders is provided, along with a brief account of neuroprotection and neuronal tissue regeneration, current clinical status, issues related to safety, toxicity, challenges, and future outlook.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Alzheimer's disease research and treatments · Graphene and Nanomaterials Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Bioengineering Rice University Houston TX 77030 USA

Department of Biochemistry and Molecular Biology Mayo Clinic College of Medicine and Science Jacksonville FL 3224 USA

Birla Institute of Technology and Science Pilani Hyderabad Telangana 500078 India

Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center 986025 Nebraska Medical Center Omaha NE 68198‐6025 USA

Division of Pulmonary and Critical Care Medicine David Geffen School of Medicine The University of California Los Angeles (UCLA) Factor Bldg. 10–240, 621 Charles E. Young Dr. Los Angeles CA 90095 USA

Aavishkar Oral Strips Pvt. Ltd. 109/3, IDA, Phase 2, Sector 2, Lane 6, Cherlapally Hyderabad Telangana 500051 India

Funding

Rice University · University of California, Los Angeles · Mayo Clinic

References (100+)

Show source-provided references
1. 10.1038/nature0529110.1038/nature05291 ↗
2. 10.1038/nature0529310.1038/nature05293 ↗
3. 10.1186/s40035-017-0077-510.1186/s40035-017-0077-5 ↗
4. 10.1016/j.semcdb.2011.04.00210.1016/j.semcdb.2011.04.002 ↗
5. 10.1126/science.106712210.1126/science.1067122 ↗
6. 10.1038/3508414110.1038/35084141 ↗
7. 10.1038/452707a10.1038/452707a ↗
8. 10.1074/jbc.R80006520010.1074/jbc.R800065200 ↗
9. 10.1016/j.biopha.2015.07.02510.1016/j.biopha.2015.07.025 ↗
10. 10.1038/nature0529210.1038/nature05292 ↗
11. 10.1016/j.neuron.2014.06.03410.1016/j.neuron.2014.06.034 ↗
12. 10.1074/jbc.M110.13957610.1074/jbc.M110.139576 ↗
13. 10.1007/s00726-009-0428-310.1007/s00726-009-0428-3 ↗
14. 10.1101/cshperspect.a02513010.1101/cshperspect.a025130 ↗
15. 10.15252/embj.20169581010.15252/embj.201695810 ↗
16. Birks J. S. · Cochrane Database Syst. Rev. · 2018 · 6 · CD001190
17. 10.1007/s12012-019-09543-810.1007/s12012-019-09543-8 ↗
18. 10.3233/JAD-19079110.3233/JAD-190791 ↗
19. 10.1001/jama.2014.365410.1001/jama.2014.3654 ↗
20. 10.3233/JHD-17028610.3233/JHD-170286 ↗
21. 10.1016/S0140-6736(07)60111-110.1016/S0140-6736(07)60111-1 ↗
22. Carlesi C. · Arch. Ital. Biol. · 2011 · 149 · 151
23. 10.1016/S1474-4422(17)30163-110.1016/S1474-4422(17)30163-1 ↗
24. 10.1177/175628561773473410.1177/1756285617734734 ↗
25. 10.1056/NEJM20010517344200610.1056/NEJM200105173442006 ↗
26. 10.1146/annurev-neuro-071714-03382810.1146/annurev-neuro-071714-033828 ↗
27. 10.1016/j.addr.2011.12.00510.1016/j.addr.2011.12.005 ↗
28. 10.1016/j.jconrel.2011.08.01710.1016/j.jconrel.2011.08.017 ↗
29. Chen W. · Adv. Mater. · 2018 · 30
30. 10.1002/adma.20150389310.1002/adma.201503893 ↗
31. 10.1016/j.nano.2017.12.00610.1016/j.nano.2017.12.006 ↗
32. 10.1016/j.neuint.2017.02.01210.1016/j.neuint.2017.02.012 ↗
33. 10.2217/nnm-2016-026710.2217/nnm-2016-0267 ↗
34. 10.1038/nm.340710.1038/nm.3407 ↗
35. 10.1016/j.nbd.2003.12.01610.1016/j.nbd.2003.12.016 ↗
36. 10.1038/nature0952210.1038/nature09522 ↗
37. 10.2174/138161282566619101417135410.2174/1381612825666191014171354 ↗
38. 10.1016/j.jconrel.2016.05.04410.1016/j.jconrel.2016.05.044 ↗
39. 10.1038/nrneurol.2017.18810.1038/nrneurol.2017.188 ↗
40. 10.1016/B978-0-12-814001-7.00007-X10.1016/B978-0-12-814001-7.00007-X ↗
41. J.Polimeni MGH Martinos Center on Twitter https://www.pinterest.com/pin/4222193378324463/(accessed: April2020).
42. 10.1002/adma.20180136210.1002/adma.201801362 ↗
43. 10.3727/00000000778346473110.3727/000000007783464731 ↗
44. 10.1002/ana.2440610.1002/ana.24406 ↗
45. 10.7150/thno.2125410.7150/thno.21254 ↗
46. 10.1016/j.jconrel.2015.12.04110.1016/j.jconrel.2015.12.041 ↗
47. 10.3389/fnins.2018.0101910.3389/fnins.2018.01019 ↗
48. 10.1124/mi.3.2.9010.1124/mi.3.2.90 ↗
49. 10.15171/bi.2016.3010.15171/bi.2016.30 ↗
50. 10.1016/j.ics.2005.02.01210.1016/j.ics.2005.02.012 ↗
51. 10.3390/cells704002410.3390/cells7040024 ↗
52. 10.1126/sciadv.aau830110.1126/sciadv.aau8301 ↗
53. 10.1002/adma.20170624510.1002/adma.201706245 ↗
54. 10.3390/ijms2002038110.3390/ijms20020381 ↗
55. 10.1039/C9NR01255A10.1039/C9NR01255A ↗
56. 10.1038/nnano.2017.5410.1038/nnano.2017.54 ↗
57. 10.1021/acs.molpharmaceut.8b0087010.1021/acs.molpharmaceut.8b00870 ↗
58. 10.1021/acsnano.7b0817210.1021/acsnano.7b08172 ↗
59. 10.2174/13892011280334185110.2174/138920112803341851 ↗
60. 10.3390/ijms2012310810.3390/ijms20123108 ↗
61. 10.1186/s40478-017-0470-410.1186/s40478-017-0470-4 ↗
62. 10.1111/cbdd.1258610.1111/cbdd.12586 ↗
63. 10.1016/j.addr.2014.01.00810.1016/j.addr.2014.01.008 ↗
64. 10.2174/15701590878577721010.2174/157015908785777210 ↗
65. 10.1016/j.bbamem.2007.09.03210.1016/j.bbamem.2007.09.032 ↗
66. 10.2174/138161282266615122115073310.2174/1381612822666151221150733 ↗
67. 10.1073/pnas.181642911510.1073/pnas.1816429115 ↗
68. 10.1038/s41392-019-0068-310.1038/s41392-019-0068-3 ↗
69. 10.2217/nnm-2018-016310.2217/nnm-2018-0163 ↗
70. 10.2147/DDDT.S4976310.2147/DDDT.S49763 ↗
71. Sintov A. C. · 2016 · 199
72. 10.2174/138161282366617010515294810.2174/1381612823666170105152948 ↗
73. 10.1016/j.actbio.2016.09.01010.1016/j.actbio.2016.09.010 ↗
74. 10.1073/pnas.151704811210.1073/pnas.1517048112 ↗
75. 10.1002/ppsc.20190019510.1002/ppsc.201900195 ↗
76. 10.3389/fncel.2020.0002110.3389/fncel.2020.00021 ↗
77. Fu T. · Neural Plast. · 2016 · 2016 · 1
78. 10.1186/s12967-018-1712-310.1186/s12967-018-1712-3 ↗
79. Wang Y. L. · Zhonghua Yixue Zazhi · 2018 · 98 · 2678
80. 10.1186/s11671-018-2638-710.1186/s11671-018-2638-7 ↗
81. 10.1021/acsomega.9b0141110.1021/acsomega.9b01411 ↗
82. 10.2217/nnm-2016-039910.2217/nnm-2016-0399 ↗
83. 10.1016/j.ajps.2018.09.00510.1016/j.ajps.2018.09.005 ↗
84. 10.1016/j.jconrel.2017.08.03310.1016/j.jconrel.2017.08.033 ↗
85. 10.2147/IJN.S11721010.2147/IJN.S117210 ↗
86. 10.1038/sj.gt.330251610.1038/sj.gt.3302516 ↗
87. 10.1155/2011/46967910.1155/2011/469679 ↗
88. 10.1016/j.nano.2017.12.00710.1016/j.nano.2017.12.007 ↗
89. 10.2147/IJN.S18311710.2147/IJN.S183117 ↗
90. 10.3390/medicines504012610.3390/medicines5040126 ↗
91. 10.1016/j.biomaterials.2016.06.01610.1016/j.biomaterials.2016.06.016 ↗
92. 10.1155/2013/27026010.1155/2013/270260 ↗
93. 10.1177/03913988090320120210.1177/039139880903201202 ↗
94. 10.3390/molecules2309223810.3390/molecules23092238 ↗
95. Šebestík J. · 2012 · 20910.1007/978-3-7091-1206-9_23 ↗
96. 10.1039/c1nj20469f10.1039/c1nj20469f ↗
97. 10.3390/pharmaceutics1004026910.3390/pharmaceutics10040269 ↗
98. 10.3390/jfb1001000410.3390/jfb10010004 ↗
99. 10.1016/j.ijpharm.2017.05.01510.1016/j.ijpharm.2017.05.015 ↗
100. 10.1016/j.jconrel.2019.03.01010.1016/j.jconrel.2019.03.010 ↗